Financial statements Mediceo Pharma
Balance sheet data of MEDICEO PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 253 620,14 | 252 749,39 | 156 308,25 | 128 619,07 | 109 241,01 | 127 442,69 |
| A. Fixed assets | 29 091,75 | 15 821,17 | 6 043,57 | 2 849,91 | 993,20 | 490,40 |
| B. Current assets | 224 528,39 | 236 928,22 | 150 264,68 | 125 769,16 | 108 247,81 | 126 952,29 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 253 620,14 | 252 749,39 | 156 308,25 | 128 619,07 | 109 241,01 | 127 442,69 |
| A. Equity | -1 051 317,90 | -1 493 964,30 | -1 857 645,74 | -2 175 884,80 | -2 636 686,36 | -2 884 092,15 |
| B. Liabilities and provisions for liabilities | 1 304 938,04 | 1 746 713,69 | 2 013 953,99 | 2 304 503,87 | 2 745 927,37 | 3 011 534,84 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.